1995
DOI: 10.1016/1047-2797(95)00066-6
|View full text |Cite
|
Sign up to set email alerts
|

Serum zinc and serum lipid profiles in 778 adults

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
15
1

Year Published

1999
1999
2015
2015

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 39 publications
1
15
1
Order By: Relevance
“…According to our data, a similar sex-dependent effect of Zn on TAG level was also reported in the SU.VI.MAX study with a multi-nutrient antioxidant supplementation containing 20 mg Zn (Hercberg et al 2005). Moreover, we did not report a negative effect of Zn supplementation on HDL status, consistent with the results of some (Crouse et al 1984;Fosmire, 1990;Hiller et al 1995;Bonham et al 2003;Hercberg et al 2005) but not all (Hooper et al 1980;Chandra, 1984;Chevalier et al 2002) studies. It seems that these results depend on the studied Zn intake, in particular when it is excessive, since in these studies, the adverse effects on HDL were described for pharmacological Zn supplementation at 50 mg/d (Black et al 1988;Chevalier et al 2002) or higher; 75 mg/d (Black et al 1988); 300 mg/d (Chandra et al 1984); 440 mg/d (Hooper et al 1980).…”
Section: Discussionsupporting
confidence: 92%
“…According to our data, a similar sex-dependent effect of Zn on TAG level was also reported in the SU.VI.MAX study with a multi-nutrient antioxidant supplementation containing 20 mg Zn (Hercberg et al 2005). Moreover, we did not report a negative effect of Zn supplementation on HDL status, consistent with the results of some (Crouse et al 1984;Fosmire, 1990;Hiller et al 1995;Bonham et al 2003;Hercberg et al 2005) but not all (Hooper et al 1980;Chandra, 1984;Chevalier et al 2002) studies. It seems that these results depend on the studied Zn intake, in particular when it is excessive, since in these studies, the adverse effects on HDL were described for pharmacological Zn supplementation at 50 mg/d (Black et al 1988;Chevalier et al 2002) or higher; 75 mg/d (Black et al 1988); 300 mg/d (Chandra et al 1984); 440 mg/d (Hooper et al 1980).…”
Section: Discussionsupporting
confidence: 92%
“…These results for iron consumption and their effect of plasma triglycerides were confirmed by various researchers [29] who observed that increasing dietary iron did not affect triglyceride concentration. On the other hand, other studies have demonstrated that higher zinc serum level were associated with higher serum triglyceride [24]. Contrarily, in the present study, zinc as ZnO or ZnSO 4 did not demonstrate such effects which might be attributed to numerous reasons like the fortificants vehicle, animal breed, and environmental factors.…”
Section: Triglyceridescontrasting
confidence: 79%
“…Serum zinc association with cholesterol has been widely reported, demonstrating serum zinc to be positively related to the total cholesterol and higher serum zinc level, most notably, those above the highest quintile were associated with higher levels of total serum cholesterol [24,25]. The current study suggested that concentration of zinc is directly associated with the plasma cholesterol concentration in rats.…”
Section: Resultsmentioning
confidence: 55%
“…Individuals, who use high-dose zinc supplementation as a potential treatment for agerelated macular degeneration, will have higher exposures to zinc. Hiller et al (1995) reported that zinc supplements will have an effect on the concentration of serum zinc in the body.…”
Section: Populations With Potentially High Exposuresmentioning
confidence: 99%